LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
0.7690
+0.0031 (0.40%)
Aug 14, 2025, 1:42 PM - Market open
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $31.69 million as of August 14, 2025. Its market cap has decreased by -64.94% in one year.
Market Cap
31.69M
Enterprise Value
83.84M
1-Year Change
-64.94%
Ranking
Category
Stock Price
0.77
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from $227.76M to $31.69M, a decrease of -86.08%. That is a compound annual growth rate of -38.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 31.56M | -52.19% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |